跳至主要内容
临床试验/NCT00747422
NCT00747422已完成不适用

Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Periorbital Wrinkles

Ulthera, Inc8 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Ulthera, Inc
入组人数
100
试验地点
8
主要终点
reduction of periorbital wrinkles

研究概览

简要总结

The purpose of this study is to look at how safe and effective the Ulthera ultrasound system is at reducing the appearance of wrinkles when used with subjects who have wrinkles around the eyes.

详细描述

The purpose of this prospective, multi-center, single treatment, clinical trial is to evaluate the effectiveness and safety of the Ulthera™ System for the non-invasive treatment of periorbital wrinkles and rhytids.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged 40 to 70 years
  • Subject in good health
  • Desire improvement in periorbital wrinkles
  • Subject provides informed consent and agrees to attend follow-up visits
  • Subject signs a HIPPA authorization

排除标准

  • Pregnant or lactating
  • Has an active systemic or local skin disease that may alter wound healing
  • Has significant scarring in test areas
  • Has significant open facial wounds or lesions
  • Has severe or cystic acne on the face
  • Has a metal stent or implant in the face area
  • Is a current smoker or has a history of smoking in last 10 years

研究组 & 干预措施

I

Experimental

干预措施: Ulthera™ System (Device)

结局指标

主要结局

reduction of periorbital wrinkles

时间窗: 3 and 6 months

次要结局

未报告次要终点

研究者

发起方
Ulthera, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验